Meta-Analysishigh evidence
Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.
Endocrinology, diabetes & metabolism·July 1, 2026·PMID 42207966
Why it mattersWith no direct head-to-head trials among these advanced anti-obesity medications, this analysis provides the best available comparative efficacy and safety estimates to guide treatment selection for substantial weight loss.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled